13.62
price up icon4.85%   0.63
after-market Dopo l'orario di chiusura: 13.57 -0.05 -0.37%
loading
Precedente Chiudi:
$12.99
Aprire:
$13.89
Volume 24 ore:
1.88M
Relative Volume:
0.48
Capitalizzazione di mercato:
$1.51B
Reddito:
$631.73M
Utile/perdita netta:
$-239.78M
Rapporto P/E:
-6.7426
EPS:
-2.02
Flusso di cassa netto:
$-33.45M
1 W Prestazione:
+10.11%
1M Prestazione:
+26.23%
6M Prestazione:
-8.59%
1 anno Prestazione:
-28.20%
Intervallo 1D:
Value
$13.54
$14.03
Intervallo di 1 settimana:
Value
$11.45
$14.03
Portata 52W:
Value
$6.78
$24.76

10 X Genomics Inc Stock (TXG) Company Profile

Name
Nome
10 X Genomics Inc
Name
Telefono
(925) 401-7300
Name
Indirizzo
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Name
Dipendente
1,306
Name
Cinguettio
@10xgenomics
Name
Prossima data di guadagno
2024-10-31
Name
Ultimi documenti SEC
Name
TXG's Discussions on Twitter

Confronta TXG con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Health Information Services icon
TXG
10 X Genomics Inc
13.62 1.60B 631.73M -239.78M -33.45M -2.02
Health Information Services icon
VEEV
Veeva Systems Inc
286.01 46.61B 2.86B 780.66M 1.20B 4.72
Health Information Services icon
TEM
Tempus Ai Inc
64.86 10.57B 803.32M -709.10M -212.68M -7.8003
Health Information Services icon
HQY
Healthequity Inc
96.91 8.42B 1.15B 96.70M -161.99M 1.09
Health Information Services icon
DOCS
Doximity Inc
61.00 11.13B 550.17M 201.35M 232.07M 1.00
Health Information Services icon
WAY
Waystar Holding Corp
36.96 6.33B 906.14M -52.62M 89.62M -0.3621

10 X Genomics Inc Stock (TXG) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-02-13 Downgrade Leerink Partners Outperform → Market Perform
2024-09-03 Iniziato Leerink Partners Outperform
2024-07-22 Aggiornamento Jefferies Hold → Buy
2024-07-18 Downgrade JP Morgan Overweight → Neutral
2024-07-10 Downgrade Deutsche Bank Buy → Hold
2024-06-27 Downgrade Wolfe Research Outperform → Peer Perform
2024-06-25 Downgrade Guggenheim Buy → Neutral
2024-06-03 Ripresa Jefferies Hold
2024-05-01 Downgrade TD Cowen Buy → Hold
2023-12-14 Iniziato Guggenheim Buy
2023-12-13 Iniziato Wolfe Research Outperform
2023-12-12 Aggiornamento BofA Securities Underperform → Neutral
2023-07-05 Ripresa JP Morgan Overweight
2023-05-10 Iniziato Barclays Overweight
2023-03-31 Iniziato Stephens Overweight
2023-02-02 Iniziato UBS Neutral
2022-12-14 Iniziato Deutsche Bank Buy
2022-08-18 Downgrade Goldman Neutral → Sell
2022-07-25 Iniziato Canaccord Genuity Buy
2022-07-15 Downgrade BofA Securities Neutral → Underperform
2022-07-15 Downgrade William Blair Outperform → Mkt Perform
2021-10-15 Ripresa Cowen Outperform
2021-09-14 Downgrade BofA Securities Buy → Neutral
2021-03-15 Iniziato William Blair Outperform
2020-12-02 Iniziato Goldman Neutral
2020-09-09 Iniziato Morgan Stanley Overweight
2020-07-10 Iniziato Stifel Buy
2020-03-05 Iniziato Guggenheim Buy
2020-01-07 Iniziato Citigroup Buy
2019-10-07 Iniziato BofA/Merrill Buy
2019-10-07 Iniziato Cowen Outperform
2019-10-07 Iniziato JP Morgan Overweight
2019-09-24 Iniziato Evercore ISI Outperform
Mostra tutto

10 X Genomics Inc Borsa (TXG) Ultime notizie

pulisher
Jul 23, 2025

What analysts say about 10x Genomics Inc. stockOutperformance with explosive growth - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Fortrea, Azenta, Bio-Techne, 10x Genomics, and Amphastar Pharmaceuticals Stocks Trade Up, What You Need To Know - Yahoo Finance

Jul 23, 2025
pulisher
Jul 22, 2025

Is 10x Genomics Inc. a good long term investmentSkyrocketing returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

10x Genomics Inc. Stock Analysis and ForecastFree Stock Index Interpretation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives 10x Genomics Inc. stock priceBreakout profit opportunities - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 18, 2025

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study - Agency for Science, Technology and Research

Jul 18, 2025
pulisher
Jul 18, 2025

Thermo Fisher, Exact Sciences, Integer Holdings, Revvity, and 10x Genomics Shares Are Falling, What You Need To Know - Yahoo Finance

Jul 18, 2025
pulisher
Jul 17, 2025

10x Genomics Ends UPC Patent Fight With Bruker - Law360

Jul 17, 2025
pulisher
Jul 17, 2025

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery - the-scientist.com

Jul 17, 2025
pulisher
Jul 14, 2025

Why 10x Genomics Inc. stock attracts strong analyst attentionFree Market Sentiment Analysis - beatles.ru

Jul 14, 2025
pulisher
Jul 11, 2025

Acadia Healthcare, 10x Genomics, Amphastar Pharmaceuticals, Myriad Genetics, and QuidelOrtho Stocks Trade Down, What You Need To Know - Yahoo Finance

Jul 11, 2025
pulisher
Jul 11, 2025

10x Genomics to Report Second Quarter 2025 Financial Results on August 7, 2025 - BioSpace

Jul 11, 2025
pulisher
Jul 03, 2025

10x Genomics Reaches Analyst Target Price - Nasdaq

Jul 03, 2025
pulisher
Jul 02, 2025

10x Genomics(TXG) Soars 7.88% on Strong Q1 Earnings - AInvest

Jul 02, 2025
pulisher
Jul 01, 2025

10x Genomics Insiders Sold US$768k Of Shares Suggesting Hesitancy - 富途牛牛

Jul 01, 2025
pulisher
Jun 30, 2025

10x Genomics, Inc.(NasdaqGS: TXG) dropped from Russell 1000 Value Index - MarketScreener

Jun 30, 2025
pulisher
Jun 29, 2025

10x Genomics, Inc.(NasdaqGS: TXG) dropped from Russell 1000 Dynamic Index - MarketScreener

Jun 29, 2025
pulisher
Jun 27, 2025

10x Genomics (TXG) Receives a Hold from Bank of America Securities - The Globe and Mail

Jun 27, 2025
pulisher
Jun 26, 2025

10x Genomics (TXG) Analyst Maintains Rating but Raises Price Target | TXG Stock News - GuruFocus

Jun 26, 2025
pulisher
Jun 23, 2025

10x Genomics: Stuck In Neutral (NASDAQ:TXG) - Seeking Alpha

Jun 23, 2025
pulisher
Jun 22, 2025

11 Best Genomics Stocks to Buy According to Hedge Funds - Insider Monkey

Jun 22, 2025
pulisher
Jun 20, 2025

Revenues Not Telling The Story For 10x Genomics, Inc. (NASDAQ:TXG) After Shares Rise 31% - simplywall.st

Jun 20, 2025
pulisher
Jun 18, 2025

10x Genomics Inc (TXG) Trading 4.12% Higher on Jun 18 - GuruFocus

Jun 18, 2025
pulisher
Jun 17, 2025

UPC Backs Sales Ban On Kits Infringing 10x Genomics Patent - Law360

Jun 17, 2025
pulisher
Jun 16, 2025

Delta, Macy's, CECO Environmental, RadNet, and 10x Genomics Shares Skyrocket, What You Need To Know - Yahoo Finance

Jun 16, 2025
pulisher
Jun 16, 2025

Layoff Tracker: Gilead Cuts 36 Employees in California - BioSpace

Jun 16, 2025
pulisher
Jun 12, 2025

Molecular Diagnostics for Cancer Market Research 2025: Advances in Personalized Medicine and Liquid Biopsies Reshape Industry Landscape - GlobeNewswire Inc.

Jun 12, 2025
pulisher
Jun 10, 2025

Brown Capital Management Small Company Fund Sold 10x Genomics (TXG) Due to Fundamental Concerns - Insider Monkey

Jun 10, 2025
pulisher
Jun 10, 2025

10x Genomics, Inc. (TXG) Stock Analysis: Evaluating A 28% Potential Upside For Investors - DirectorsTalk Interviews

Jun 10, 2025
pulisher
Jun 04, 2025

Forecasting The Future: 7 Analyst Projections For 10x Genomics - Benzinga

Jun 04, 2025
pulisher
Jun 04, 2025

Long Read Sequencing Market Key Players Analysis10X Genomics, - openPR.com

Jun 04, 2025
pulisher
Jun 04, 2025

10x Genomics, Inc. (NASDAQ:TXG) Stock Holdings Increased by Deutsche Bank AG - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

ARK Investment Acquires 290K Shares of 10x Genomics (TXG) | TXG Stock News - GuruFocus

Jun 03, 2025

10 X Genomics Inc Azioni (TXG) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$10.80
price up icon 1.69%
$21.39
price up icon 1.33%
$20.30
price up icon 1.15%
$47.05
price up icon 0.79%
$21.30
price up icon 5.71%
health_information_services WAY
$36.96
price up icon 1.07%
Capitalizzazione:     |  Volume (24 ore):